Bio-Rad Laboratories Price to Sales Ratio 2010-2025 | BIO
Historical PS ratio values for Bio-Rad Laboratories (BIO) over the last 10 years. The current P/S ratio for Bio-Rad Laboratories as of June 23, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Bio-Rad Laboratories P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-06-23 | 235.54 | 2.61 | |
| 2025-03-31 | 243.56 | $90.30 | 2.70 |
| 2024-12-31 | 328.51 | $90.76 | 3.62 |
| 2024-09-30 | 334.58 | $90.43 | 3.70 |
| 2024-06-30 | 273.11 | $88.84 | 3.07 |
| 2024-03-31 | 345.87 | $89.56 | 3.86 |
| 2023-12-31 | 322.89 | $90.91 | 3.55 |
| 2023-09-30 | 358.45 | $92.10 | 3.89 |
| 2023-06-30 | 379.12 | $93.37 | 4.06 |
| 2023-03-31 | 479.02 | $93.36 | 5.13 |
| 2022-12-31 | 420.49 | $94.00 | 4.47 |
| 2022-09-30 | 417.14 | $93.74 | 4.45 |
| 2022-06-30 | 495.00 | $95.56 | 5.18 |
| 2022-03-31 | 563.23 | $96.11 | 5.86 |
| 2021-12-31 | 755.57 | $96.80 | 7.81 |
| 2021-09-30 | 745.95 | $98.73 | 7.56 |
| 2021-06-30 | 644.29 | $95.50 | 6.75 |
| 2021-03-31 | 571.17 | $89.61 | 6.37 |
| 2020-12-31 | 582.94 | $84.46 | 6.90 |
| 2020-09-30 | 515.46 | $78.96 | 6.53 |
| 2020-06-30 | 451.49 | $76.27 | 5.92 |
| 2020-03-31 | 350.56 | $77.40 | 4.53 |
| 2019-12-31 | 370.03 | $76.87 | 4.81 |
| 2019-09-30 | 332.74 | $76.59 | 4.34 |
| 2019-06-30 | 312.59 | $75.79 | 4.12 |
| 2019-03-31 | 305.68 | $75.86 | 4.03 |
| 2018-12-31 | 232.22 | $75.74 | 3.07 |
| 2018-09-30 | 312.99 | $76.02 | 4.12 |
| 2018-06-30 | 288.54 | $75.80 | 3.81 |
| 2018-03-31 | 250.08 | $73.56 | 3.40 |
| 2017-12-31 | 238.67 | $72.00 | 3.31 |
| 2017-09-30 | 222.22 | $70.59 | 3.15 |
| 2017-06-30 | 226.31 | $69.96 | 3.23 |
| 2017-03-31 | 199.34 | $70.61 | 2.82 |
| 2016-12-31 | 182.28 | $69.86 | 2.61 |
| 2016-09-30 | 163.81 | $69.98 | 2.34 |
| 2016-06-30 | 143.02 | $68.80 | 2.08 |
| 2016-03-31 | 136.72 | $68.56 | 1.99 |
| 2015-12-31 | 138.66 | $68.73 | 2.02 |
| 2015-09-30 | 134.31 | $69.87 | 1.92 |
| 2015-06-30 | 150.61 | $72.11 | 2.09 |
| 2015-03-31 | 135.18 | $73.34 | 1.84 |
| 2014-12-31 | 120.56 | $74.72 | 1.61 |
| 2014-09-30 | 113.40 | $75.04 | 1.51 |
| 2014-06-30 | 119.71 | $74.49 | 1.61 |
| 2014-03-31 | 128.12 | $74.23 | 1.73 |
| 2013-12-31 | 123.61 | $74.04 | 1.67 |
| 2013-09-30 | 117.56 | $73.23 | 1.61 |
| 2013-06-30 | 112.20 | $72.98 | 1.54 |
| 2013-03-31 | 126.00 | $72.62 | 1.73 |
| 2012-12-31 | 105.05 | $72.32 | 1.45 |
| 2012-09-30 | 106.72 | $71.61 | 1.49 |
| 2012-06-30 | 100.01 | $72.35 | 1.38 |
| 2012-03-31 | 103.69 | $72.82 | 1.42 |
| 2011-12-31 | 96.04 | $72.87 | 1.32 |
| 2011-09-30 | 90.77 | $72.51 | 1.25 |
| 2011-06-30 | 119.36 | $71.13 | 1.68 |
| 2011-03-31 | 120.14 | $69.45 | 1.73 |
| 2010-12-31 | 103.85 | $68.55 | 1.52 |
| 2010-09-30 | 90.51 | $67.38 | 1.34 |
| 2010-06-30 | 86.49 | $67.14 | 1.29 |
| 2010-03-31 | 103.52 | $65.91 | 1.57 |
| 2009-12-31 | 96.46 | $64.25 | 1.50 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.442B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.811B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |